{"id":1629,"date":"2014-02-24T19:48:59","date_gmt":"2014-02-24T18:48:59","guid":{"rendered":"http:\/\/slanedeti.sk\/cms\/?p=1629"},"modified":"2014-02-24T19:48:59","modified_gmt":"2014-02-24T18:48:59","slug":"zhodnotenie-vysledkov-4-cast","status":"publish","type":"post","link":"https:\/\/slanedeti.sk\/cms\/zhodnotenie-vysledkov-4-cast\/1629","title":{"rendered":"Zhodnotenie v\u00fdsledkov – 4.\u010das\u0165"},"content":{"rendered":"

V na\u0161ej pr\u00e1ci sme zis\u0165ovali kvalitu \u017eivota poci\u0165ovan\u00fa dospel\u00fdmi pacientmi s cystickou fibr\u00f3zou. Zamerali sme sa konkr\u00e9tne na rozdiely medzi pacientmi s r\u00f4zne z\u00e1va\u017en\u00fdm zdravotn\u00fdm stavom a tie\u017e na genderov\u00e9 a vekov\u00e9 rozdiely v kvalite \u017eivota. Nie je n\u00e1m zn\u00e1me, \u017ee by sa doposia\u013e in\u00e1 pr\u00e1ca na Slovensku venovala zis\u0165ovaniu subjekt\u00edvne pre\u017e\u00edvanej kvality \u017eivota u pacientov s cystickou fibr\u00f3zou v s\u00favislosti so z\u00e1va\u017enos\u0165ou zdravotn\u00e9ho stavu.<\/p>\n

Prim\u00e1rne sme sk\u00famali rozdiely v pre\u017e\u00edvanej kvalite \u017eivota medzi pacientmi s r\u00f4znym stup\u0148om z\u00e1va\u017enosti zdravotn\u00e9ho stavu. V\u00fdsledky potvrdili n\u00e1\u0161 predpoklad, \u017ee pacienti so zl\u00fdm i s priemern\u00fdm zdravotn\u00fdm stavom v porovnan\u00ed s pacientmi dosahuj\u00facimi dobr\u00fd zdravotn\u00fd stav poci\u0165uj\u00fa zn\u00ed\u017een\u00fa kvalitu \u017eivota. Bli\u017e\u0161ie sme tie\u017e analyzovali vybran\u00e9 dimenzie kvality \u017eivota, a to respira\u010dn\u00e9 sympt\u00f3my a fyzick\u00e9 fungovanie. Predpokladali sme, \u017ee pacienti so zl\u00fdm zdravotn\u00fdm stavom bud\u00fa vykazova\u0165 z\u00e1va\u017enej\u0161ie respira\u010dn\u00e9 sympt\u00f3my a zhor\u0161en\u00e9 fyzick\u00e9 fungovanie ako pacienti s dobr\u00fdm zdravotn\u00fdm stavom. V\u00fdsledky preuk\u00e1zali, \u017ee pacienti s CF so zl\u00fdm zdravotn\u00fdm stavom poci\u0165ovali v\u00fdznamn\u00e9 zhor\u0161enie v t\u00fdchto vybran\u00fdch dimenzi\u00e1ch kvality \u017eivota, ktor\u00e9 bolo v\u00fdraznej\u0161ie ako u pacientov s dobr\u00fdm zdravotn\u00fdm stavom. Jednotlivci so zl\u00fdm zdravotn\u00fdm stavom poci\u0165ovali v\u00e4\u010d\u0161ie \u0165a\u017ekosti pri vykon\u00e1van\u00ed fyzick\u00fdch aktiv\u00edt, pri zotavovan\u00ed sa po fyzickej n\u00e1mahe, pri dv\u00edhan\u00ed \u0165a\u017ek\u00fdch predmetov, pri vystupovan\u00ed po schodoch i pri samotnej ch\u00f4dzi. Z\u00e1va\u017enej\u0161ie boli tie\u017e poci\u0165ovan\u00e9 respira\u010dn\u00e9 sympt\u00f3my pacientmi so zhor\u0161en\u00fdm stavom. Tieto sympt\u00f3my zah\u0155\u0148ali p\u00edskanie v p\u013e\u00facach, \u0165a\u017ekosti pri d\u00fdchan\u00ed, \u010dast\u00e9 ka\u0161lanie po\u010das d\u0148a, pocit zahlienen\u00fdch p\u013e\u00fac \u010di probl\u00e9my so sp\u00e1nkom sp\u00f4soben\u00e9 ka\u0161\u013eom. N\u00e1sledn\u00e1 anal\u00fdza zvy\u0161n\u00fdch dimenzi\u00ed kvality \u017eivota preuk\u00e1zala, \u017ee pacienti so zl\u00fdm zdravotn\u00fdm stavom poci\u0165uj\u00fa v\u00fdznamne zn\u00ed\u017een\u00fa kvalitu \u017eivota aj v dimenzi\u00e1ch obraz tela, hmotnos\u0165, soci\u00e1lne fungovanie, rolov\u00e9 fungovanie, emocion\u00e1lne fungovanie, vn\u00edmanie zdravia a vitalita.<\/p>\n

Zn\u00ed\u017eenie spirometrick\u00fdch parametrov, charakteristick\u00e9 poklesom hodnoty FEV1 m\u00f4\u017ee zna\u010di\u0165 pr\u00edtomnos\u0165 ob\u0161trukcie \u010di re\u0161trikcie r\u00f4zneho stup\u0148a, \u010do znamen\u00e1 obmedzenie prietoku vzduchu d\u00fdchac\u00edmi cestami. Toto obmedzenie je zapr\u00ed\u010dinen\u00e9 z\u00fa\u017een\u00edm d\u00fdchac\u00edch ciest v d\u00f4sledku zhrubnutia steny bronchov a bronchiol \u010di nahromaden\u00fdm hlienom v d\u00fdchac\u00edch cest\u00e1ch, \u010do m\u00e1 za n\u00e1sledok s\u0165a\u017een\u00e9 d\u00fdchanie. Je zrejm\u00e9, \u017ee zhor\u0161en\u00e9 spirometrick\u00e9 parametre reprezentuj\u00fa nepriazniv\u00fd zdravotn\u00fd stav, ktor\u00fd sa prejavuje najm\u00e4 v poklese zvl\u00e1dania fyzickej z\u00e1\u0165a\u017ee, v z\u00e1va\u017enej\u0161\u00edch respira\u010dn\u00fdch sympt\u00f3moch ako aj v celkovom oslaben\u00ed fyzick\u00e9ho fungovania. Deterior\u00e1cia p\u013e\u00facnych funkci\u00ed teda \u00fazko s\u00favis\u00ed so zhor\u0161en\u00edm celkov\u00e9ho fyzick\u00e9ho stavu. Oslaben\u00e9 d\u00fdchanie znemo\u017e\u0148uje pacientom vykon\u00e1vanie mnoh\u00fdch \u010dinnost\u00ed a fyzick\u00fdch aktiv\u00edt, \u010do m\u00e1 znovu nepriazniv\u00fd vplyv na p\u013e\u00facne funkcie. Postupn\u00e9 zhor\u0161ovanie p\u013e\u00facnych funkci\u00ed sa st\u00e1va ireverzibiln\u00e9.<\/p>\n

Na\u0161e zistenia o zn\u00ed\u017eenej kvalite \u017eivota pre\u017e\u00edvanej pacientmi s hor\u0161\u00edm stavom a tie\u017e o \u0161pecifickom zhor\u0161en\u00ed respira\u010dn\u00fdch sympt\u00f3mov a fyzick\u00e9ho fungovanie, s\u00fa v s\u00falade s mno\u017estvom predo\u0161l\u00fdch v\u00fdskumov. Zisten\u00fd bol pozit\u00edvny vz\u0165ah medzi hodnotami FEV1 a FVC a dimenziami kvality \u017eivota fyzick\u00e9 fungovanie a respira\u010dn\u00e9 sympt\u00f3my. Pokles v hodnot\u00e1ch FEV1 a FVC bol spojen\u00fd s poklesom v celkovej kvalite \u017eivota. Zn\u00ed\u017eenie spirometrick\u00fdch parametrov bolo obzvl\u00e1\u0161\u0165 vidite\u013en\u00e9 v spom\u00ednan\u00fdch dvoch dimenzi\u00e1ch. Pacienti zaraden\u00ed na z\u00e1klade spirometrick\u00fdch parametrov do skupiny s lep\u0161\u00edm zdravotn\u00fdm stavom poci\u0165ovali vy\u0161\u0161iu kvalitu \u017eivota v dimenzi\u00e1ch respira\u010dn\u00e9 sympt\u00f3my a fyzick\u00e9 fungovanie v porovnan\u00ed so skupinou s hor\u0161\u00edm stavom (Schmidt et al., 2009). V \u010fal\u0161\u00edch v\u00fdskumoch pacienti s dobr\u00fdm stavom poci\u0165ovali vy\u0161\u0161iu kvalitu \u017eivota vo v\u00e4\u010d\u0161ine dimenzi\u00ed s v\u00fdnimkou za\u017e\u00edvac\u00edch sympt\u00f3mov alebo poci\u0165ovali komplexne lep\u0161\u00ed fyzick\u00fd stav. Fyzick\u00e9 fungovanie sa tie\u017e preuk\u00e1zalo ako v\u00fdznamn\u00fd predik\u010dn\u00fd faktor pre\u017eitia a relevantn\u00fd prognostick\u00fd \u00fadaj.<\/p>\n

\"diskusia\"<\/a><\/p>\n

Zauj\u00edmali n\u00e1s tie\u017e genderov\u00e9 rozdiely v pre\u017e\u00edvanej kvalite \u017eivota pacientmi s CF. N\u00e1\u0161 predpoklad, \u017ee \u017eeny poci\u0165uj\u00fa ni\u017e\u0161iu celkov\u00fa kvalitu \u017eivota sme na z\u00e1klade v\u00fdsledkov zamietli. Pr\u00ed\u010din m\u00f4\u017ee by\u0165 nieko\u013eko. Stoto\u017e\u0148ujeme sa s n\u00e1zorom viacer\u00fdch autorov, ktor\u00ed nazna\u010duj\u00fa rozdiely v zvl\u00e1dac\u00edch strat\u00e9gi\u00e1ch a ich vyu\u017e\u00edvan\u00ed medzi mu\u017emi a \u017eenami. U \u017eien bola zisten\u00e1 presnej\u0161ia percepcia objekt\u00edvneho zdravotn\u00e9ho stavu a tie\u017e \u010dastej\u0161ie vyu\u017e\u00edvanie zvl\u00e1dac\u00edch strat\u00e9gi\u00ed, \u0161peci\u00e1lne popierania. \u017deny maj\u00fa tendenciu vyu\u017e\u00edva\u0165 \u00fa\u010dinnej\u0161ie zvl\u00e1dacie strat\u00e9gie, \u010do m\u00f4\u017ee by\u0165 d\u00f4sledkom r\u00f4znych skuto\u010dnost\u00ed. V porovnan\u00ed s mu\u017emi m\u00f4\u017eu ma\u0165 \u017eeny ni\u017e\u0161ie o\u010dak\u00e1vania, preto\u017ee mu\u017ei sa aj napriek ochoreniu pova\u017euj\u00fa za \u017eivite\u013eov v spolo\u010dnosti a za t\u00fdch, ktor\u00fdch \u00falohou je postara\u0165 sa o rodinu. \u017deny si zvykn\u00fa vybudova\u0165 lep\u0161iu rodinn\u00fa a soci\u00e1lnu podporu, ktor\u00e1 im pom\u00e1ha v zvl\u00e1dan\u00ed ich ochorenia a akcept\u00e1cii zn\u00ed\u017eenej kvality \u017eivota. Pre podrobnej\u0161ie presk\u00famanie problematiky sme n\u00e1sledne zis\u0165ovali rozdiely aj v jednotliv\u00fdch dimenzi\u00e1ch kvality \u017eivota. Napriek tomu, \u017ee \u017eeny dosiahli ni\u017e\u0161ie priemern\u00e9 sk\u00f3re vo v\u0161etk\u00fdch dimenzi\u00e1ch okrem dimenzie hmotnos\u0165 a obraz tela, v\u00fdznamn\u00e9 zhor\u0161enie poci\u0165ovali iba v za\u017e\u00edvac\u00edch sympt\u00f3mom, fyzickom fungovan\u00ed, vitalite a soci\u00e1lnom fungovan\u00ed.<\/p>\n

Viacer\u00e9 v\u00fdskumy vyu\u017e\u00edvaj\u00face CFQ-R zistili v\u00fdznamn\u00e9 genderov\u00e9 rozdiely v poci\u0165ovanej kvalite \u017eivota a to pr\u00e1ve v dimenzi\u00e1ch obraz tela a hmotnos\u0165. \u010co sa t\u00fdka ni\u017e\u0161ieho sk\u00f3re vo vn\u00edman\u00ed obrazu tela u mu\u017eov v na\u0161om v\u00fdskume, zistenie je v s\u00falade s v\u00fdskumom kvality \u017eivota a genderov\u00fdch rozdielov u pacientov s CF, v ktorom \u017eeny poci\u0165ovali ni\u017e\u0161iu kvalitu \u017eivota vo v\u0161etk\u00fdch dimenzi\u00e1ch s v\u00fdnimkou obrazu tela, v ktorom vy\u0161\u0161ie sk\u00f3re dosiahli mu\u017ei. Napriek tomu, \u017ee v dimenzii obraz tela dosiahli \u017eeny vy\u0161\u0161ie sk\u00f3re sa toto zistenie nepreuk\u00e1zalo ako v\u00fdznamn\u00e9. Je v\u0161ak pozoruhodn\u00e9, \u017ee mu\u017ei vn\u00edmali svoju hmotnos\u0165 v\u00fdznamne hor\u0161ie ako \u017eeny, pova\u017eovali sa toti\u017e v\u00e4\u010d\u0161inou za pr\u00edli\u0161 chud\u00fdch. M\u00f4\u017ee to nasved\u010dova\u0165 tomu, \u017ee \u017eeny nevn\u00edmaj\u00fa svoju hmotnos\u0165 nato\u013eko negat\u00edvne ako mu\u017ei napriek tomu, ak je ich hmotnos\u0165 objekt\u00edvne pr\u00edli\u0161 n\u00edzka. Dokonca sa zd\u00e1, \u017ee \u017eeny s CF s\u00fa so svojou \u0161t\u00edhlos\u0165ou a n\u00edzkou hmotnos\u0165ou spokojn\u00e9. Mu\u017ei naopak m\u00f4\u017eu by\u0165 na svoju zn\u00ed\u017een\u00fa hmotnos\u0165 citlivej\u0161\u00ed, ke\u010f\u017ee spolo\u010dnos\u0165 prij\u00edma pozit\u00edvnej\u0161ie ni\u017e\u0161iu hmotnos\u0165 u \u017eien ne\u017e mu\u017eov. M\u00f4\u017ee to by\u0165 v d\u00f4sledku ist\u00fdch kult\u00farnych \u0161tandardov a predst\u00e1v o ide\u00e1lnej postave mu\u017ea ako siln\u00e9ho a urasten\u00e9ho a ide\u00e1lnej postave \u017eeny ako \u0161t\u00edhlej a drobnej.<\/p>\n

V\u00fdsledky n\u00e1\u0161ho v\u00fdskumu si vysvet\u013eujeme v s\u00falade s n\u00e1zorom in\u00fdch autorov, ktor\u00ed sk\u00famali genderov\u00e9 rozdiely vo vn\u00edman\u00ed hmotnosti pacientmi s CF. \u017deny s CF s\u00fa znev\u00fdhodnen\u00e9 oproti mu\u017eom s CF, pri\u010dom k tomuto znev\u00fdhodneniu patr\u00ed pr\u00e1ve slab\u0161\u00ed nutri\u010dn\u00fd status. V\u00fdznamne v\u00e4\u010d\u0161\u00ed podiel \u017eien (v porovnan\u00ed s mu\u017emi), ktor\u00e9 boli mierne a\u017e v\u00fdrazne podvy\u017eiven\u00e9, ohodnotilo svoju hmotnos\u0165 ako norm\u00e1lnu, \u010di dokonca a\u017e zv\u00fd\u0161en\u00fa. Naopak v\u00fdznamne v\u00e4\u010d\u0161ie percento mu\u017eov (v porovnan\u00ed so \u017eenami), ktor\u00ed vykazovali norm\u00e1lnu hmotnos\u0165, sa pokladalo za pr\u00edli\u0161 chud\u00fdch a\u017e podvy\u017eiven\u00fdch. Mu\u017ei \u010dasto vypovedali o t\u00fa\u017ebe zv\u00fd\u0161i\u0165 svoju hmotnos\u0165. Vn\u00edmanie vlastnej hmotnosti u pacientov s CF n\u00e1sledne s\u00favis\u00ed s u\u017e\u00edvan\u00edm v\u00fd\u017eivov\u00fdch doplnkov, pri\u010dom tieto doplnky stravy u\u017e\u00edva v\u00fdznamne viac pacientov, ktor\u00ed sa pokladaj\u00fa za pr\u00edli\u0161 chud\u00fdch, v porovnan\u00ed s t\u00fdmi, ktor\u00ed svoju hmotnos\u0165 pova\u017euj\u00fa za norm\u00e1lnu. Z t\u00fdchto zisten\u00ed vypl\u00fdva, \u017ee mlad\u00e9 \u017eeny s CF maj\u00fa tendenciu prece\u0148ova\u0165 svoju hmotnos\u0165, pri\u010dom mu\u017ei svoju hmotnos\u0165 naopak podce\u0148uj\u00fa. Toto skreslenie vo vn\u00edman\u00ed hmotnosti u pacientov s CF m\u00f4\u017ee by\u0165 potenci\u00e1lnym rizikom pre ich zdravotn\u00fd stav, ke\u010f\u017ee s vn\u00edman\u00edm hmotnosti s\u00favis\u00ed u\u017e\u00edvanie doplnkov stravy na zv\u00fd\u0161enie hmotnosti. Chybn\u00e9 vn\u00edmanie je teda nebezpe\u010dn\u00e9 najm\u00e4 u \u017eien, ktor\u00e9 m\u00f4\u017eu ma\u0165 tendenciu z\u00e1merne udr\u017eiava\u0165 svoju n\u00edzku hmotnos\u0165 \u010di ju e\u0161te zni\u017eova\u0165 v domnienke, \u017ee je dostato\u010dn\u00e1. Je preto d\u00f4le\u017eit\u00e9 sna\u017ei\u0165 sa u pacientov s CF (obzvl\u00e1\u0161\u0165 u \u017eien) dosiahnu\u0165 realistick\u00e9 vn\u00edmanie vlastnej hmotnosti, nako\u013eko nutri\u010dn\u00fd stav je spojen\u00fd s celkov\u00fdm zdravotn\u00fdm stavom a d\u013a\u017ekou pre\u017eitia.<\/p>\n

Bli\u017e\u0161ie sme tie\u017e sk\u00famali vekov\u00e9 rozdiely v pre\u017e\u00edvanej kvalite \u017eivota medzi pacientmi s CF. Predpokladom, ktor\u00fd sme testovali v na\u0161om v\u00fdskume, bola zn\u00ed\u017een\u00e1 kvalita \u017eivota u star\u0161\u00edch pacientov v porovnan\u00ed s mlad\u0161\u00edmi pacientmi. Ten sme v\u0161ak na z\u00e1klade v\u00fdsledkov zamietli. N\u00e1\u0161 predpoklad vypl\u00fdval najm\u00e4 z progres\u00edvnej povahy ochorenia, pre ktor\u00e9 je charakteristick\u00e1 postupn\u00e1 deterior\u00e1cia fyzick\u00e9ho stavu, sp\u00f4soben\u00e1 najm\u00e4 zhor\u0161ovan\u00edm p\u013e\u00facnych funkci\u00ed. Taktie\u017e limit\u00e1cie so zvy\u0161uj\u00facim sa vekom prib\u00fadaj\u00fa a pacient je obmedzovan\u00fd v mnoh\u00fdch \u010dinnostiach, ktor\u00e9 s\u00fa samozrejm\u00e9 pre zdrav\u00fdch \u013eud\u00ed. Pri\u0165a\u017euj\u00facou okolnos\u0165ou m\u00f4\u017ee by\u0165 tie\u017e fakt, \u017ee pacienti a\u017e vo vy\u0161\u0161om veku komplexne ch\u00e1pu podstatu a d\u00f4sledky svojho ochorenia. Musia sa zmieri\u0165 s najz\u00e1va\u017enej\u0161\u00edmi skuto\u010dnos\u0165ami, a to s t\u00fdm, \u017ee cystick\u00e1 fibr\u00f3za je \u017eivot skracuj\u00facim a nevylie\u010dite\u013en\u00fdm ochoren\u00edm. Tieto atrib\u00faty ochorenia mlad\u0161\u00ed pacienti e\u0161te nie s\u00fa schopn\u00ed dostato\u010dne kognit\u00edvne uchopi\u0165 a anticipova\u0165 n\u00e1sledky do bud\u00facnosti. V\u00fdsledky n\u00e1\u0161ho v\u00fdskumu v\u0161ak popieraj\u00fa, \u017ee by star\u0161\u00ed pacienti poci\u0165ovali v\u00fdznamn\u00e9 zhor\u0161enie kvality \u017eivota v porovnan\u00ed s mlad\u0161\u00edmi pacientmi. M\u00f4\u017ee to by\u0165 sp\u00f4soben\u00e9 skuto\u010dnos\u0165ou, \u017ee n\u00e1\u0161ho v\u00fdskumu sa z\u00fa\u010dastnilo v\u00e4\u010d\u0161ie mno\u017estvo mlad\u0161\u00edch pacientov vo veku 18 a\u017e 25 rokov a menej pacientov nad 30 rokov. Taktie\u017e si mysl\u00edme, \u017ee rozdiel v pre\u017e\u00edvanej kvalite \u017eivota by bol v\u00e4\u010d\u0161\u00ed pri sk\u00faman\u00ed \u0161ir\u0161ieho vekov\u00e9ho rozp\u00e4tia, ako napr\u00edklad porovn\u00e1vanie kvality \u017eivota u det\u00ed s CF a dospel\u00fdch s CF. \u010eal\u0161ou skuto\u010dnos\u0165ou, ktor\u00e1 m\u00f4\u017ee interferova\u0165 s\u00fa zvl\u00e1dacie strat\u00e9gie. Pacienti vy\u0161\u0161ieho veku m\u00f4\u017eu by\u0165 lep\u0161ie adaptovan\u00ed na svoje ochorenie, m\u00f4\u017eu ma\u0165 vytvoren\u00e9 \u00fa\u010dinnej\u0161ie zvl\u00e1dacie strat\u00e9gie a teda objekt\u00edvne hor\u0161iu kvalitu \u017eivota m\u00f4\u017eu subjekt\u00edvne vn\u00edma\u0165 ako posta\u010duj\u00facu. Naopak mlad\u0161\u00ed pacienti m\u00f4\u017eu zhor\u0161ovanie stavu pre\u017e\u00edva\u0165 v\u00fdraznej\u0161ie, ke\u010f\u017ee v detstve vn\u00edman\u00e9 \u0165a\u017ekosti nemuseli by\u0165 nato\u013eko z\u00e1va\u017en\u00e9. Zvl\u00e1dacie strat\u00e9gie nemusia by\u0165 e\u0161te posta\u010duj\u00face, preto mo\u017eno zn\u00ed\u017een\u00fa kvalitu svojho \u017eivota nezvl\u00e1daj\u00fa nato\u013eko ako star\u0161\u00ed pacienti. To spolo\u010dne m\u00f4\u017ee vies\u0165 ku kritickej\u0161iemu posudzovaniu kvality \u017eivota.<\/p>\n

Zamietnutie n\u00e1\u0161ho predpokladu o ni\u017e\u0161ej kvalite \u017eivota star\u0161\u00edch pacientov je v protiklade so zisteniami nieko\u013ek\u00fdch autorov. Vo v\u0161eobecnosti vykazuj\u00fa mlad\u0161\u00ed pacienti s CF celkovo lep\u0161\u00ed zdravotn\u00fd stav, \u010do nazna\u010duje aj vy\u0161\u0161iu kvalitu \u017eivota. Vo v\u00fdskume, kde bola porovn\u00e1van\u00e1 poci\u0165ovan\u00e1 kvalita \u017eivota star\u0161\u00edch dospel\u00fdch pacientov s CF a mlad\u0161\u00edch dospel\u00fdch s CF, pri\u010dom star\u0161\u00ed dospel\u00ed poci\u0165ovali ni\u017e\u0161iu kvalitu \u017eivota. Existoval v\u00fdznamn\u00fd vz\u0165ah medzi vekom a dosiahnutou celkovou kvalitou \u017eivota v tomto dotazn\u00edku, pri\u010dom deti s CF poci\u0165ovali vy\u0161\u0161iu kvalitu \u017eivota takmer vo v\u0161etk\u00fdch oblastiach. Aj in\u00e9 v\u00fdskumy nazna\u010duj\u00fa vy\u0161\u0161iu kvalitu \u017eivota v ni\u017e\u0161om veku, zisten\u00e9 bolo v\u00fdznamne lep\u0161ie vn\u00edmanie obrazu tela, lep\u0161ie zvl\u00e1danie z\u00e1\u0165a\u017ee lie\u010dby a celkovo priaznivej\u0161\u00ed emocion\u00e1lny stav u mlad\u0161\u00edch pacientov.<\/p>\n

S predo\u0161l\u00fdmi uveden\u00fdmi zisteniami \u00fazko s\u00favis\u00ed n\u00e1\u0161 \u010fal\u0161\u00ed predpoklad, ktor\u00fd sme overovali vo v\u00fdskumnej ot\u00e1zke. O\u010dak\u00e1vali sme, \u017ee star\u0161\u00ed pacienti bud\u00fa poci\u0165ova\u0165 z\u00e1va\u017enej\u0161ie respira\u010dn\u00e9 sympt\u00f3my, zhor\u0161en\u00e9 fyzick\u00e9 fungovanie a ni\u017e\u0161iu vitalitu v porovnan\u00ed s mlad\u0161\u00edmi pacientmi. Ke\u010f\u017ee tieto dimenzie najviac vypovedaj\u00fa o zdravotnom stave, s progresiou ochorenia sprev\u00e1dzanou vekom by sa v nich mali negat\u00edvne zmeny prejavi\u0165 najv\u00fdraznej\u0161ie. V\u00fdsledky potvrdzuj\u00fa v\u00fdznamne zhor\u0161en\u00e9 fyzick\u00e9 fungovanie a tie\u017e v\u00fdznamne zn\u00ed\u017een\u00fa poci\u0165ovan\u00fa vitalitu u star\u0161\u00edch pacientov. Star\u0161\u00ed pacienti sa zriedkavej\u0161ie c\u00edtili dobre \u010di pln\u00ed energie, \u010dasto sa naopak c\u00edtili unavene a vy\u010derpane. Star\u0161\u00ed pacienti mali tie\u017e v\u00e4\u010d\u0161ie \u0165a\u017ekosti pri vykon\u00e1van\u00ed fyzick\u00fdch aktiv\u00edt, pri vystupovan\u00ed po schodoch \u010di pri ch\u00f4dzi. Napriek tomu, \u017ee star\u0161\u00ed pacienti v porovnan\u00ed s mlad\u0161\u00edmi dosiahli ni\u017e\u0161ie priemern\u00e9 sk\u00f3re v dimenzii respira\u010dn\u00e9 sympt\u00f3my, rozdiel prekvapivo nebol v\u00fdznamn\u00fd. Vysvetlen\u00edm m\u00f4\u017ee by\u0165, \u017ee pri respira\u010dn\u00fdch sympt\u00f3moch nie je vek nato\u013eko rozhoduj\u00facim faktorom, ako napr\u00edklad z\u00e1va\u017enos\u0165 zdravotn\u00e9ho stavu. Pacienti s CF toti\u017e respira\u010dn\u00e9 sympt\u00f3my poci\u0165uj\u00fa u\u017e od detstva a ich zhor\u0161enie pravdepodobne viac s\u00favis\u00ed so zhor\u0161en\u00edm celkov\u00e9ho zdravotn\u00e9ho stavu ako so zvy\u0161uj\u00facim sa vekom. Pr\u00ed\u010dinou tie\u017e m\u00f4\u017ee by\u0165, \u017ee pacienti sa v priebehu rokov na z\u00e1va\u017enej\u0161ie respira\u010dn\u00e9 sympt\u00f3my adaptuj\u00fa a nato\u013eko ich nevn\u00edmaj\u00fa. V\u00e4\u010d\u0161\u00ed o\u010dak\u00e1van\u00fd rozdiel by mohol by\u0165 zisten\u00fd pri porovn\u00e1van\u00ed skupiny det\u00ed s CF a dospel\u00fdch s CF, ako tomu bolo v niektor\u00fdch predo\u0161l\u00fdch v\u00fdskumoch.<\/p>\n

Pr\u00edloha 1: Hrub\u00e9 sk\u00f3re celkovej kvality \u017eivota a jednotliv\u00fdch dimenzi\u00ed kvality \u017eivota v skupine mu\u017eov a \u017eien<\/em><\/strong>
\n

\n\n\n\n\n<\/colgroup>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
<\/td>\nMu\u017ei<\/td>\n\u017deny<\/td>\n<\/tr>\n
Celkov\u00e9 sk\u00f3re<\/td>\n143,81<\/td>\n136,51<\/td>\n<\/tr>\n
Emocion\u00e1lne fungovanie<\/td>\n14,48<\/td>\n14,16<\/td>\n<\/tr>\n
Obraz tela<\/td>\n8,26<\/td>\n9,27<\/td>\n<\/tr>\n
Soci\u00e1lne fungovanie<\/td>\n19,41<\/td>\n17,33<\/td>\n<\/tr>\n
Vitalita<\/td>\n11,19<\/td>\n10,20<\/td>\n<\/tr>\n
Rolov\u00e9 fungovanie<\/td>\n11,78<\/td>\n11,65<\/td>\n<\/tr>\n
Fyzick\u00e9 fungovanie<\/td>\n24,59<\/td>\n21,33<\/td>\n<\/tr>\n
Poruchy jedenia<\/td>\n10,70<\/td>\n10,47<\/td>\n<\/tr>\n
Z\u00e1\u0165a\u017e zo strany lie\u010dby<\/td>\n7,93<\/td>\n7,86<\/td>\n<\/tr>\n
Vn\u00edmanie zdravia<\/td>\n8,26<\/td>\n7,45<\/td>\n<\/tr>\n
Hmotnos\u0165<\/td>\n1,85<\/td>\n2,51<\/td>\n<\/tr>\n
Respira\u010dn\u00e9 sympt\u00f3my<\/td>\n13,59<\/td>\n13,41<\/td>\n<\/tr>\n
Za\u017e\u00edvacie sympt\u00f3my<\/td>\n9,78<\/td>\n8,84<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n

Pr\u00edloha 2: Hrub\u00e9 sk\u00f3re celkovej kvality \u017eivota a jednotliv\u00fdch dimenzi\u00ed kvality \u017eivota v skupine mlad\u0161\u00edch (V1) a star\u0161\u00edch pacientov (V2)<\/em><\/strong><\/p>\n

\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
<\/td>\nMlad\u0161\u00ed pacienti (V1)<\/td>\nStar\u0161\u00ed pacienti (V2)<\/td>\n<\/tr>\n
Celkov\u00e9 sk\u00f3re<\/td>\n140,59<\/td>\n136,83<\/td>\n<\/tr>\n
Emocion\u00e1lne fungovanie<\/td>\n14,20<\/td>\n14,40<\/td>\n<\/tr>\n
Obraz tela<\/td>\n8,39<\/td>\n9,70<\/td>\n<\/tr>\n
Soci\u00e1lne fungovanie<\/td>\n18,13<\/td>\n17,97<\/td>\n<\/tr>\n
Vitalita<\/td>\n10,93<\/td>\n9,97<\/td>\n<\/tr>\n
Rolov\u00e9 fungovanie<\/td>\n11,87<\/td>\n11,43<\/td>\n<\/tr>\n
Fyzick\u00e9 fungovanie<\/td>\n23,98<\/td>\n20,20<\/td>\n<\/tr>\n
Poruchy jedenia<\/td>\n10,43<\/td>\n10,73<\/td>\n<\/tr>\n
Z\u00e1\u0165a\u017e zo strany lie\u010dby<\/td>\n7,70<\/td>\n8,17<\/td>\n<\/tr>\n
Vn\u00edmanie zdravia<\/td>\n8,02<\/td>\n7,30<\/td>\n<\/tr>\n
Hmotnos\u0165<\/td>\n2,13<\/td>\n2,50<\/td>\n<\/tr>\n
Respira\u010dn\u00e9 sympt\u00f3my<\/td>\n13,59<\/td>\n13,30<\/td>\n<\/tr>\n
Za\u017e\u00edvacie sympt\u00f3my<\/td>\n9,20<\/td>\n9,13<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n

 <\/p>\n

Pr\u00edloha 3: Hrub\u00e9 sk\u00f3re celkovej kvality \u017eivota a jednotliv\u00fdch dimenzi\u00ed kvality \u017eivota v skupine pacientov s dobr\u00fdm zdravotn\u00fdm stavom (S1), s priemern\u00fdm zdravotn\u00fdm stavom (S2) a zl\u00fdm zdravotn\u00fdm stavom (S3)<\/em><\/strong><\/p>\n

\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
<\/td>\nPacienti s dobr\u00fdm zdravotn\u00fdm stavom (S1)<\/td>\nPacienti s priemern\u00fdm zdravotn\u00fdm stavom (S2)<\/td>\nPacienti
\nso zl\u00fdm zdravotn\u00fdm stavom (S3)<\/td>\n<\/tr>\n
Celkov\u00e9 sk\u00f3re<\/td>\n153,91<\/td>\n138,16<\/td>\n113,82<\/td>\n<\/tr>\n
Emocion\u00e1lne fungovanie<\/td>\n15,30<\/td>\n14,69<\/td>\n12,27<\/td>\n<\/tr>\n
Obraz tela<\/td>\n9,91<\/td>\n9,19<\/td>\n7,27<\/td>\n<\/tr>\n
Soci\u00e1lne fungovanie<\/td>\n19,30<\/td>\n18,19<\/td>\n16,36<\/td>\n<\/tr>\n
Vitalita<\/td>\n11,39<\/td>\n10,34<\/td>\n9,00<\/td>\n<\/tr>\n
Rolov\u00e9 fungovanie<\/td>\n12,43<\/td>\n12,00<\/td>\n9,27<\/td>\n<\/tr>\n
Fyzick\u00e9 fungovanie<\/td>\n27,17<\/td>\n21,66<\/td>\n13,82<\/td>\n<\/tr>\n
Poruchy jedenia<\/td>\n11,09<\/td>\n10,50<\/td>\n9,55<\/td>\n<\/tr>\n
Z\u00e1\u0165a\u017e zo strany lie\u010dby<\/td>\n8,48<\/td>\n7,69<\/td>\n7,45<\/td>\n<\/tr>\n
Vn\u00edmanie zdravia<\/td>\n9,17<\/td>\n7,59<\/td>\n5,18<\/td>\n<\/tr>\n
Hmotnos\u0165<\/td>\n2,70<\/td>\n2,41<\/td>\n1,45<\/td>\n<\/tr>\n
Respira\u010dn\u00e9 sympt\u00f3my<\/td>\n15,78<\/td>\n12,72<\/td>\n11,73<\/td>\n<\/tr>\n
Za\u017e\u00edvacie sympt\u00f3my<\/td>\n9,04<\/td>\n9,13<\/td>\n9,09<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

V našej práci sme zisťovali kvalitu života pociťovanú dospelými pacientmi s cystickou fibrózou. Zamerali sme sa konkrétne na rozdiely medzi pacientmi s rôzne závažným zdravotným stavom a tiež na genderové a vekové rozdiely v kvalite života. Nie je nám známe, … Continued<\/a><\/p>\n","protected":false},"author":10,"featured_media":1630,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"kt_blocks_editor_width":"","footnotes":""},"categories":[253],"tags":[],"class_list":["post-1629","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-o-cystickej-fibroze"],"yoast_head":"\nZhodnotenie v\u00fdsledkov - 4.\u010das\u0165 - Slan\u00e9 deti<\/title>\n<meta name=\"description\" content=\"V\u00fdsledky pr\u00e1ce o kvalite \u017eivota poci\u0165ovanej dospel\u00fdmi pacientmi s cystickou fibr\u00f3zou.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/slanedeti.sk\/cms\/zhodnotenie-vysledkov-4-cast\/1629\" \/>\n<meta property=\"og:locale\" content=\"sk_SK\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Zhodnotenie v\u00fdsledkov - 4.\u010das\u0165 - Slan\u00e9 deti\" \/>\n<meta property=\"og:description\" content=\"V\u00fdsledky pr\u00e1ce o kvalite \u017eivota poci\u0165ovanej dospel\u00fdmi pacientmi s cystickou fibr\u00f3zou.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/slanedeti.sk\/cms\/zhodnotenie-vysledkov-4-cast\/1629\" \/>\n<meta property=\"og:site_name\" content=\"Slan\u00e9 deti\" \/>\n<meta property=\"article:publisher\" content=\"http:\/\/www.facebook.com\/slanedeti\" \/>\n<meta property=\"article:published_time\" content=\"2014-02-24T18:48:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/slanedeti.sk\/cms\/wp-content\/uploads\/2014\/02\/diskusia_clanok.png\" \/>\n\t<meta property=\"og:image:width\" content=\"450\" \/>\n\t<meta property=\"og:image:height\" content=\"450\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Martina Ondreji\u010dkov\u00e1\" \/>\n<meta name=\"twitter:label1\" content=\"Autor\" \/>\n\t<meta name=\"twitter:data1\" content=\"Martina Ondreji\u010dkov\u00e1\" \/>\n\t<meta name=\"twitter:label2\" content=\"Predpokladan\u00fd \u010das \u010d\u00edtania\" \/>\n\t<meta name=\"twitter:data2\" content=\"13 min\u00fat\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/zhodnotenie-vysledkov-4-cast\\\/1629#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/zhodnotenie-vysledkov-4-cast\\\/1629\"},\"author\":{\"name\":\"Martina Ondreji\u010dkov\u00e1\",\"@id\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/#\\\/schema\\\/person\\\/533fb80bc91e78157014b20fef001594\"},\"headline\":\"Zhodnotenie v\u00fdsledkov – 4.\u010das\u0165\",\"datePublished\":\"2014-02-24T18:48:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/zhodnotenie-vysledkov-4-cast\\\/1629\"},\"wordCount\":2660,\"image\":{\"@id\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/zhodnotenie-vysledkov-4-cast\\\/1629#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/wp-content\\\/uploads\\\/2014\\\/02\\\/diskusia_clanok.png\",\"articleSection\":[\"O cystickej fibr\u00f3ze\"],\"inLanguage\":\"sk-SK\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/zhodnotenie-vysledkov-4-cast\\\/1629\",\"url\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/zhodnotenie-vysledkov-4-cast\\\/1629\",\"name\":\"Zhodnotenie v\u00fdsledkov - 4.\u010das\u0165 - Slan\u00e9 deti\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/zhodnotenie-vysledkov-4-cast\\\/1629#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/zhodnotenie-vysledkov-4-cast\\\/1629#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/wp-content\\\/uploads\\\/2014\\\/02\\\/diskusia_clanok.png\",\"datePublished\":\"2014-02-24T18:48:59+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/#\\\/schema\\\/person\\\/533fb80bc91e78157014b20fef001594\"},\"description\":\"V\u00fdsledky pr\u00e1ce o kvalite \u017eivota poci\u0165ovanej dospel\u00fdmi pacientmi s cystickou fibr\u00f3zou.\",\"inLanguage\":\"sk-SK\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/zhodnotenie-vysledkov-4-cast\\\/1629\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"sk-SK\",\"@id\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/zhodnotenie-vysledkov-4-cast\\\/1629#primaryimage\",\"url\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/wp-content\\\/uploads\\\/2014\\\/02\\\/diskusia_clanok.png\",\"contentUrl\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/wp-content\\\/uploads\\\/2014\\\/02\\\/diskusia_clanok.png\",\"width\":450,\"height\":450},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/#website\",\"url\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/\",\"name\":\"Slan\u00e9 deti\",\"description\":\"Inform\u00e1cie o cystickej fibr\u00f3ze\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sk-SK\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/#\\\/schema\\\/person\\\/533fb80bc91e78157014b20fef001594\",\"name\":\"Martina Ondreji\u010dkov\u00e1\",\"url\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/author\\\/martina\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Zhodnotenie v\u00fdsledkov - 4.\u010das\u0165 - Slan\u00e9 deti","description":"V\u00fdsledky pr\u00e1ce o kvalite \u017eivota poci\u0165ovanej dospel\u00fdmi pacientmi s cystickou fibr\u00f3zou.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/slanedeti.sk\/cms\/zhodnotenie-vysledkov-4-cast\/1629","og_locale":"sk_SK","og_type":"article","og_title":"Zhodnotenie v\u00fdsledkov - 4.\u010das\u0165 - Slan\u00e9 deti","og_description":"V\u00fdsledky pr\u00e1ce o kvalite \u017eivota poci\u0165ovanej dospel\u00fdmi pacientmi s cystickou fibr\u00f3zou.","og_url":"https:\/\/slanedeti.sk\/cms\/zhodnotenie-vysledkov-4-cast\/1629","og_site_name":"Slan\u00e9 deti","article_publisher":"http:\/\/www.facebook.com\/slanedeti","article_published_time":"2014-02-24T18:48:59+00:00","og_image":[{"width":450,"height":450,"url":"https:\/\/slanedeti.sk\/cms\/wp-content\/uploads\/2014\/02\/diskusia_clanok.png","type":"image\/png"}],"author":"Martina Ondreji\u010dkov\u00e1","twitter_misc":{"Autor":"Martina Ondreji\u010dkov\u00e1","Predpokladan\u00fd \u010das \u010d\u00edtania":"13 min\u00fat"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/slanedeti.sk\/cms\/zhodnotenie-vysledkov-4-cast\/1629#article","isPartOf":{"@id":"https:\/\/slanedeti.sk\/cms\/zhodnotenie-vysledkov-4-cast\/1629"},"author":{"name":"Martina Ondreji\u010dkov\u00e1","@id":"https:\/\/slanedeti.sk\/cms\/#\/schema\/person\/533fb80bc91e78157014b20fef001594"},"headline":"Zhodnotenie v\u00fdsledkov – 4.\u010das\u0165","datePublished":"2014-02-24T18:48:59+00:00","mainEntityOfPage":{"@id":"https:\/\/slanedeti.sk\/cms\/zhodnotenie-vysledkov-4-cast\/1629"},"wordCount":2660,"image":{"@id":"https:\/\/slanedeti.sk\/cms\/zhodnotenie-vysledkov-4-cast\/1629#primaryimage"},"thumbnailUrl":"https:\/\/slanedeti.sk\/cms\/wp-content\/uploads\/2014\/02\/diskusia_clanok.png","articleSection":["O cystickej fibr\u00f3ze"],"inLanguage":"sk-SK"},{"@type":"WebPage","@id":"https:\/\/slanedeti.sk\/cms\/zhodnotenie-vysledkov-4-cast\/1629","url":"https:\/\/slanedeti.sk\/cms\/zhodnotenie-vysledkov-4-cast\/1629","name":"Zhodnotenie v\u00fdsledkov - 4.\u010das\u0165 - Slan\u00e9 deti","isPartOf":{"@id":"https:\/\/slanedeti.sk\/cms\/#website"},"primaryImageOfPage":{"@id":"https:\/\/slanedeti.sk\/cms\/zhodnotenie-vysledkov-4-cast\/1629#primaryimage"},"image":{"@id":"https:\/\/slanedeti.sk\/cms\/zhodnotenie-vysledkov-4-cast\/1629#primaryimage"},"thumbnailUrl":"https:\/\/slanedeti.sk\/cms\/wp-content\/uploads\/2014\/02\/diskusia_clanok.png","datePublished":"2014-02-24T18:48:59+00:00","author":{"@id":"https:\/\/slanedeti.sk\/cms\/#\/schema\/person\/533fb80bc91e78157014b20fef001594"},"description":"V\u00fdsledky pr\u00e1ce o kvalite \u017eivota poci\u0165ovanej dospel\u00fdmi pacientmi s cystickou fibr\u00f3zou.","inLanguage":"sk-SK","potentialAction":[{"@type":"ReadAction","target":["https:\/\/slanedeti.sk\/cms\/zhodnotenie-vysledkov-4-cast\/1629"]}]},{"@type":"ImageObject","inLanguage":"sk-SK","@id":"https:\/\/slanedeti.sk\/cms\/zhodnotenie-vysledkov-4-cast\/1629#primaryimage","url":"https:\/\/slanedeti.sk\/cms\/wp-content\/uploads\/2014\/02\/diskusia_clanok.png","contentUrl":"https:\/\/slanedeti.sk\/cms\/wp-content\/uploads\/2014\/02\/diskusia_clanok.png","width":450,"height":450},{"@type":"WebSite","@id":"https:\/\/slanedeti.sk\/cms\/#website","url":"https:\/\/slanedeti.sk\/cms\/","name":"Slan\u00e9 deti","description":"Inform\u00e1cie o cystickej fibr\u00f3ze","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/slanedeti.sk\/cms\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sk-SK"},{"@type":"Person","@id":"https:\/\/slanedeti.sk\/cms\/#\/schema\/person\/533fb80bc91e78157014b20fef001594","name":"Martina Ondreji\u010dkov\u00e1","url":"https:\/\/slanedeti.sk\/cms\/author\/martina"}]}},"_links":{"self":[{"href":"https:\/\/slanedeti.sk\/cms\/wp-json\/wp\/v2\/posts\/1629","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/slanedeti.sk\/cms\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/slanedeti.sk\/cms\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/slanedeti.sk\/cms\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/slanedeti.sk\/cms\/wp-json\/wp\/v2\/comments?post=1629"}],"version-history":[{"count":0,"href":"https:\/\/slanedeti.sk\/cms\/wp-json\/wp\/v2\/posts\/1629\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/slanedeti.sk\/cms\/wp-json\/wp\/v2\/media\/1630"}],"wp:attachment":[{"href":"https:\/\/slanedeti.sk\/cms\/wp-json\/wp\/v2\/media?parent=1629"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/slanedeti.sk\/cms\/wp-json\/wp\/v2\/categories?post=1629"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/slanedeti.sk\/cms\/wp-json\/wp\/v2\/tags?post=1629"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}